"Descrizione" by Al222 (19776 pt) | 2023-Dec-28 19:53 |
Evaluation | N. Experts | Evaluation | N. Experts |
---|---|---|---|
1 | 6 | ||
2 | 7 | ||
3 | 8 | ||
4 | 9 | ||
5 | 10 |
Components that help in anthelmintic action are substances that can contribute to eliminating or inhibiting intestinal parasites. Here are some examples
The anthelmintic drugs fight against nematodes, gastrointestinal parasites. Albendazole, fenbendazole, mebendazole, oxibendazole, parbendazole , flubendazole belong to the family of benzimidazole and exercise anthelmintic activity.
The reports provided on Tiiips website are for informational purposes only and should not replace medical advice. Always consult a healthcare professional before making health-related decisions.
Components that can contribute to or exacerbate helminthic infections include various factors that can increase the risk of worm infestations. Here are some examples
Studies
In Vitro Anthelmintic Activity of Saponins from Medicago spp. Against Sheep Gastrointestinal Nematodes. Maestrini M, Tava A, Mancini S, Tedesco D, Perrucci S. Molecules. 2020 Jan 7;25(2). pii: E242. doi: 10.3390/molecules25020242
Anthelmintics in the future: current trends in the discovery and development of new drugs against gastrointestinal nematodes. Zajíčková M, Nguyen LT, Skálová L, Raisová Stuchlíková L, Matoušková P. Drug Discov Today. 2019 Dec 26. pii: S1359-6446(19)30466-0. doi: 10.1016/j.drudis.2019.12.007.
Effects of cholesterol content on activity of P-glycoproteins and membrane physical state, and consequences for anthelmintic resistance in the nematode Haemonchus contortus. Riou M, Guégnard F, Le Vern Y, Grasseau I, Koch C, Blesbois E, Kerboeuf D. Parasite. 2020;27:3. doi: 10.1051/parasite/2019079.
Schistosomiasis and hookworm infection in humans: Disease burden, pathobiology and anthelmintic vaccines. Anisuzzaman, Tsuji N. Parasitol Int. 2020 Jan 3;75:102051. doi: 10.1016/j.parint.2020.102051.
The Benzimidazole-Based Anthelmintic Parbendazole: A Repurposed Drug Candidate That Synergizes with Gemcitabine in Pancreatic Cancer. Florio R, Veschi S, di Giacomo V, Pagotto S, Carradori S, Verginelli F, Cirilli R, Casulli A, Grassadonia A, Tinari N, Cataldi A, Amoroso R, Cama A, De Lellis L. Cancers (Basel). 2019 Dec 17;11(12). pii: E2042. doi: 10.3390/cancers11122042.
Evaluate |